Who invested in Ablaze Pharmaceuticals?
Ablaze Pharmaceuticals's investors include Venrock, Vivo Capital and Samsara BioCapital.
Who invested in Ablaze Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $75MNov 2021
- Investors
- 3
The rounds
- Nov 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ablaze Pharmaceuticals
How much has Ablaze Pharmaceuticals raised?
Ablaze Pharmaceuticals has raised $75M across 1 round since 2021.
When did Ablaze Pharmaceuticals last raise?
Ablaze Pharmaceuticals's most recent round was a Series A of $75M in Nov 2021.
What was Ablaze Pharmaceuticals's biggest round?
Its most recent round, $75M in Nov 2021, is also its largest on record.
Who backed Ablaze Pharmaceuticals first?
Ablaze Pharmaceuticals's first round on record, in Nov 2021, was backed by Venrock, Vivo Capital and Samsara BioCapital.
What stage is Ablaze Pharmaceuticals at?
Ablaze Pharmaceuticals's latest named round is a Series A, in Nov 2021.
Companies like Ablaze Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.